Democrats' Congress win adds scrutiny to Trump drug-pricing deals with pharma

The Democrats' landslide win across Congress is adding scrutiny to President Donald Trump's confidential drug-pricing deals with pharmaceutical companies, with key lawmakers promising probes into patient savings.

Detected & updated continuously · Source: Nebula